🇺🇸 FDA
Pipeline program

Fostamatinib disodium

C-935788-057

Phase 3 small_molecule active

Quick answer

Fostamatinib disodium for Warm Antibody Autoimmune Hemolytic Anemia is a Phase 3 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).

Program details

Company
RIGEL PHARMACEUTICALS INC
Indication
Warm Antibody Autoimmune Hemolytic Anemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials